"about"
Displaying search results from 10 results are found.
PRODUCTS
CONTENT
CystoAssist Endourologic Platform
What doctors are saying about CystoAssist™
“The true benefit of the device is that it allowed a rigid cystoscope sheath to be held in position aligned with the ureteral orifice and facilitated placement of the ureteral access sheath when the sheath was previously buckling in the bladder and could not be advanced even over a super stiff wire.”
"I was able to use the cystoscope sheath to access the ureter without dilating and it was easy to get in and out of the ureter"
“With cystoscope sheath in the bladder, the bladder is kept empty, preventing over distention during a longer ureteroscopic case.”
“With a large prostate gland, maintaining the scope sheath in a static position avoids its movement and prevents it rubbing on the bladder neck which can cause troublesome bleeding and obscure vision.”
“During stent placement, I was able to stand further away from the image intensifier and fluoroscopy source, reducing my exposure to radiation.”
“CystoAssist facilitates passage of the stent without an assistant as I could hold the working wire and advance the stent without having to have a hand on the cystoscope sheath.”
Schelin Catheter
About the schelin catheter
The Catheter is a CE-marked* device for injections of legally marketed drugs into the prostate. At first glance the Schelin Catheter® looks like a normal urinary catheter but it has an extra channel through which a thermoplastic cannula is inserted. The cannula is connected to a syringe and thus drugs can be injected directly into the prostate in a sterile transurethral way.
When local anaesthesia is administered with the Schelin Catheter:
- Pain & discomfort is decreased
- The risk of pathogens from the rectum to enter the body is eliminated
- The need for general anaesthesia is eliminated
* Not approved in US, China & other MDSAP countries
Fasciotens Abdomen-177
Revolution in open abdominal therapy
What is different about using Fasciotens® solution?
Preventing abdominal wall retraction
By applying vertical traction to the abdominal wall immediately, retraction of the lateral abdominal muscles can be prevented. Especially in the early phase of open abdominal therapy, horizontal traction cannot be applied sufficiently. In contrast, vertical traction can be applied from the very beginning, regardless of the degree of intestinal edema, and ultimately accelerates the final closure of the abdominal wall at the end of the treatment.
Immobilization of the patient*
The technique of applying vertical traction to the abdominal wall increases the intra-abdominal volume. The expansion of the abdominal cavity causes a decrease in intra-abdominal pressure (determining the IAP is one of the most important factors in patient stabilization.
Easy integration into daily intensive care routines
The device is designed to be used seamlessly in the intensive care unit. It can be removed and reattached in seconds for emergencies or patient care. Training the intensive care team is a vital part of our orientation process. We make sure to support you in the best possible way.
Seamless combination with NPWT
fasciotens® can be easily combined with other techniques such as negative pressure wound therapy (NPWT). We have prepared a step-by-step guide for applying the wound dressing.
How does it work?
Vertical traction is the solution to succeed in open abdomen treatment
The fasciotens®Abdomen device applies controlled vertical traction to the abdominal wall. It increases the volume of the abdominal cavity and thus reduces the intra-abdominal pressure. This can have beneficial effects on lung function, organ perfusion and renal output*.
Additionally, the device prevents fascial retraction, facilitating direct closure after the oedema decreases. Revision surgeries or "planned" incisional hernias become much less likely.
Fasciotens Hernia-178
Frequently Asked Questions
Why should I add another technique to my repertoire?
fasciotens®Hernia is a powerful tool in your toolbox. While traditional methods can close most of the hernias, they come with a list of side effects and trade-offs. Recently, wide discussions arose about whether less invasive treatments should be utilised more regularly. fasciotens® allows a high rate of direct fascial closure.
Can I combine the fasciotens®Hernia therapy with other techniques?
Absolutely! Depending on the patient's condition and medical history, different techniques can or should be added to our approach. In many cases, a pre-treatment with Botox proved to be a successful combination. fasciotens® can also be used in laparoscopic and robotic procedures.
What's the procedure for my first application?
Just reach out to your local fasciotens partner or directly to us. One of our surgeons or fasciotens® specialists will discuss your case with you and together we agree on whether fasciotens is suitable. We will make sure that you will have a fasciotens® expert at your side during the treatment.
How long does the treatment with fasciotens®Hernia take?
That depends largely on your patient's condition. The device will be applied exclusively in the OR. After preparation (e.g. retrorectus dissection) the device is set up and fascial traction is normally carried out for approx. 30 minutes. In most cases the fascial edges can be closed directly afterwards.
What do I have to tell my anaesthesiologist?
Since you will apply traction among others to the muscles of the abdominal wall, the patient should be under full muscle relaxation during the whole procedure. Besides that, your in-house standards can be applied.
RestoreX
Restore function with
our clinically proven product
In cooperation with Mayo Clinic, PathRight Medical completed two clinical studies enrolling over 100 men total. The first trial compared men using RestoreX for 30, 60 or 90 minutes per day in 1,2 or 3 30-minute sessions against a control group, i.e. a group that did not do any treatment at all. A link to the 3 month appears below as well as a link to the same group followed out to 6 months. The 3 month results were published in the Journal of Urology in June 2019 and the 6 month results presented at a recent Urology conference (March 2019). Additionally, a study was completed using RestoreX in combination with Xiaflex injections. This study was also published and appeared in the Journal of Sexual Medicine in 2019. Click the link below to be directed to the study results of combination therapy with Xiaflex.
Key Findings include:
3-month data
- 94% of men regained lost length, with an average of 1.6cm or 11%
- 77% of men experienced a reduction in curvature that average 17 degrees or 28%
- 80% of men unable to have penetrative sex at the start of the trial were able to after 12 weeks of RestoreX treatment
- 89% preferred RestoreX over other traction devices
- Men with mild to moderate Erectile Dysfunction demonstrated statistically significant improvement in Erectile Function
- No long term complications were associated with RestoreX treatment.
- Transient, short term complications included temporary changes in color, numbness and temperature of the penile glans.
Combination with Xiaflex
- Curve reduction increased 70% when using RestoreX with Xiaflex vs Xiaflex alone.
Instructions for Use
Please consult with your doctor, or other qualified health care professional before using any of our products. The information provided is designed for educational purposes only. You should not rely on this information as a substitute for, nor does it replace, professional medical advice, diagnosis, or treatment. If you have any concerns or questions about your health, you should always consult with a physician or other health-care professional. Do not disregard, avoid or delay obtaining medical or health related advice from your health-care professional because of something you may have read here. The use of any information provided is solely at your own risk.